SENTÉ Announces Issuance of a New United States Patent For Heparan Sulfate
San Diego, Calif., Oct. 17, 2016 — SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced that the company has received a new patent grant, Process For The Purification Of Heparan Sulfate And Use Thereof In Cosmetological And Dermatological Preparations (U.S. Patent No. 9,4330,099) by the United States Patent and Trademark Office (USPTO). The company’s patent estate has now produced patents in Europe and the United States, further strengthening its ability to distribute innovative skin care products worldwide.
“The issuance of this patent is a major milestone for the company and comes at a time when we are gaining significant traction” said Laurent Combredet, Chief Executive Officer. “This further solidifies our IP position and adds to our vision of becoming a leading aesthetics company dedicated to pioneering glycosaminoglycan science.”
“Our focus is to remain dedicated to the development of products based on rigorous science and clinical research” said Faheem Hasnain, Chairman of the Board of Directors. “This patent grant allows us to continue developing innovative and market disrupting technologies in the US and abroad”.
About SENTÉ:
SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted medical skincare products based on glycosaminoglycans. Founded in 2007 and based in San Diego, California, further information may be found at https://sentelabs.com/. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
SENTÉ®, an innovative specialty aesthetics company, is pleased to announce a partnership with Skinuva® as the exclusive US Professional Sales Partner of Skinuva® Scar. Skinuva® Scar is a patented,...
New collaborations will increase access to SENTÉ’s patented sulfated glycosaminoglycan analog technology for aesthetic providers and their patients seeking innovative skin rejuvenation products Carlsbad, Calif., December 11, 2018 – SENTÉ,...
SAN DIEGO, February 9, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans,...
Capital To Further Expand Commercial Operations And Broaden Product Portfolio SAN DIEGO, February 5, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated...
Confident Skin Starts Here
At Senté, we're one of the top three fastest-growing brands dispensed by physicians since 2019. Our products are created with active, innovative, and efficacious formulas designed to reveal healthier-looking skin, no matter your age or skin type.
Join out mailing list to stay informed about the latest updates, promotions, products, and best ways to care for your skin.